Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00177788 · ClinicalTrials.gov registry record
Voriconazole as Prophylaxis for Liver Transplant Recipients
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 800
- Enrollment target
NCT00177788: Completed study, sponsored by University of Pittsburgh.
NCT00177788 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 800 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00177788 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 800 participants
- Enrollment target
Study Summary
The study aims to determine if voriconazole prevents invasive fungal infections in liver transplant recipients. Endpoints would be: occurrence of invasive fungal infection and fungal colonization. Two groups will be compared: patients who received voriconazole as prophylaxis and historical controls who did not receive this prophylaxis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2005-09 |
| Est. Completion | 2012-08 |
What the finished NCT00177788 record still lists
NCT00177788 is an observational study that tracks outcomes without assigning an intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00177788 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00177788 about?
NCT00177788 is a clinical study titled "Voriconazole as Prophylaxis for Liver Transplant Recipients". The study aims to determine if voriconazole prevents invasive fungal infections in liver transplant recipients. Endpoints would be: occurrence of invasive fungal infection and fungal colonization. Two groups will be compared: patients who received voriconazole as prophylaxis and historical controls ...
What is the current status of trial NCT00177788?
This trial is currently completed. The enrollment target is 800 participants. The study started on 2005-09. Estimated completion is 2012-08.
Who is sponsoring clinical trial NCT00177788?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia